Testicular Cancer Vaccines
Creative Biolabs is a world leader in the field of cancer vaccine development. With our extensive experience and advanced platform, we are therefore confident in offering the best services for testicular cancer vaccine development and guarantee the finest results for our customers all over the world.
Testicular Cancer
Testicular cancer is a cancer which develops in the testicles, a part of the m ale reproductive system. It is the most common male neoplasm occurring in men between the ages of 20 and 34. Symptoms may include a testicular lump or swelling or pain in the scrotum. The most common type is germ cell tumors, including seminoma and non-seminoma. Other types include lymphomas and sex cord stromal tumors. Risk factors include family history, undescended testis, and testicular cancer history. Cryptorchidism is a major risk factor for the development of testicular cancer. It is generally believed that the presence of a tumor contributes to cryptorchidism; when cryptorchidism occurs with a tumor, the tumor tends to be larger. Other risk factors include inguinal hernia, Klinefelter's syndrome, and mumps orchitis. Testicular cancer is highly curable. Treatment options may include surgery, chemotherapy, radiotherapy, or stem cell transplantation. Treatment may lead to infertility.
Therapeutic Vaccines for Testicular Cancer
In order to improve the treatment of testicular cancer, Creative Biolabs have been focus on the development of therapeutic vaccines for testicular cancer. Such vaccines boost the body's natural tumor defense and help eliminate local and systemic metastases. Moreover, vaccines can be administered as adjuvant therapy in conjunction with standard care that is currently involved in surgery and chemotherapy.
Inhibins are proteins secreted by Sertoli and Leydig cells, which reduces the pituitary release of follicle stimulating hormone (FSH). Inhibins are heterodimeric glycoproteins which contain a single alpha-chain and one of two beta-chain forms, held together by a single disulfide bond. Thus, there are two inhibins, namely inhibin-α and inhibin-β which belong to the transforming growth factor-β (TGFβ) superfamily. Therefore, inhibin is an important regulator of spermatogenesis. Inhibin-α is expressed in many testicular tumors. Targeted immune response to inhibin-α can inhibit the growth of mouse testicular stromal tumors. Tumor growth inhibition is evident both in the treatment and prophylaxis and is effective against both autochthonous and transplanted tumors. These findings provide a reasonable basis for the development of immune control of testicular cancer.
Creative Biolabs is a leader in the field of vaccine development and has focused on the cancer vaccines for years. We have experts who are able to help you with the development of the testicular cancer vaccines. If you are interested in our services, please contact us for more details.
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.
